語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
到查詢結果
[ subject:"Melatonin." ]
切換:
標籤
|
MARC模式
|
ISBD
Melatonin, neuroprotective agents an...
~
Lopez-Munoz, Francisco.
Melatonin, neuroprotective agents and antidepressant therapy
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Melatonin, neuroprotective agents and antidepressant therapyedited by Francisco Lopez-Munoz ... [et al.].
其他作者:
Lopez-Munoz, Francisco.
出版者:
New Delhi :Springer India :2016.
面頁冊數:
xxv, 921 p. :ill., digital ;24 cm.
Contained By:
Springer eBooks
標題:
Melatonin.
電子資源:
http://dx.doi.org/10.1007/978-81-322-2803-5
ISBN:
9788132228035$q(electronic bk.)
Melatonin, neuroprotective agents and antidepressant therapy
Melatonin, neuroprotective agents and antidepressant therapy
[electronic resource] /edited by Francisco Lopez-Munoz ... [et al.]. - New Delhi :Springer India :2016. - xxv, 921 p. :ill., digital ;24 cm.
This work is a guidebook for clinicians who are involved in treating depressive patients and also serves the research scientists who are working on the psychopharmacological mechanisms of antidepressant actions and psychopathological mechanisms underlying mood disorders. Mood disorders such as major depressive disorder (MDD), bipolar disorder (BPD) and seasonal affective disorder (SAD) are the most disabling disorders that are among the most expensive of all medical illnesses. The pathophysiology of mood disorders is very complex and involves many mechanisms like circadian rhythm disruption, sleep abnormalities, melatonin rhythm abnormalities and alterations in melatonin receptor mechanisms, abnormalities in monoaminergic neurotransmitter mechanisms, glutamatergic release mechanisms, hippocampal neurogenesis, and abnormal immune and cytokine release mechanisms. Many antidepressants that are in clinical use today including the recently introduced novel agents like agomelatine or other antidepressants cause clinical remission by resynchronizing disrupted circadian rhythms and melatonin receptor functions, enhancing monoaminergic neurotransmission, promoting hippocampal neurogenesis, and regulating immune mechanisms. This book explains various etiological factors that are involved in the pathogenesis of mood disorders and the mechanisms of therapeutic actions of antidepressants including the recently introduced agomelatine and other antidepressants that exhibit rapid onset of action with greater efficacy and fewer side effects.
ISBN: 9788132228035$q(electronic bk.)
Standard No.: 10.1007/978-81-322-2803-5doiSubjects--Topical Terms:
649179
Melatonin.
LC Class. No.: RM297.M44
Dewey Class. No.: 615.78
Melatonin, neuroprotective agents and antidepressant therapy
LDR
:02491nmm a2200301 a 4500
001
500075
003
DE-He213
005
20161117101939.0
006
m d
007
cr nn 008maaau
008
170621s2016 ii s 0 eng d
020
$a
9788132228035$q(electronic bk.)
020
$a
9788132228011$q(paper)
024
7
$a
10.1007/978-81-322-2803-5
$2
doi
035
$a
978-81-322-2803-5
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RM297.M44
072
7
$a
MJN
$2
bicssc
072
7
$a
MED056000
$2
bisacsh
082
0 4
$a
615.78
$2
23
090
$a
RM297.M44
$b
M517 2016
245
0 0
$a
Melatonin, neuroprotective agents and antidepressant therapy
$h
[electronic resource] /
$c
edited by Francisco Lopez-Munoz ... [et al.].
260
$a
New Delhi :
$b
Springer India :
$b
Imprint: Springer,
$c
2016.
300
$a
xxv, 921 p. :
$b
ill., digital ;
$c
24 cm.
520
$a
This work is a guidebook for clinicians who are involved in treating depressive patients and also serves the research scientists who are working on the psychopharmacological mechanisms of antidepressant actions and psychopathological mechanisms underlying mood disorders. Mood disorders such as major depressive disorder (MDD), bipolar disorder (BPD) and seasonal affective disorder (SAD) are the most disabling disorders that are among the most expensive of all medical illnesses. The pathophysiology of mood disorders is very complex and involves many mechanisms like circadian rhythm disruption, sleep abnormalities, melatonin rhythm abnormalities and alterations in melatonin receptor mechanisms, abnormalities in monoaminergic neurotransmitter mechanisms, glutamatergic release mechanisms, hippocampal neurogenesis, and abnormal immune and cytokine release mechanisms. Many antidepressants that are in clinical use today including the recently introduced novel agents like agomelatine or other antidepressants cause clinical remission by resynchronizing disrupted circadian rhythms and melatonin receptor functions, enhancing monoaminergic neurotransmission, promoting hippocampal neurogenesis, and regulating immune mechanisms. This book explains various etiological factors that are involved in the pathogenesis of mood disorders and the mechanisms of therapeutic actions of antidepressants including the recently introduced agomelatine and other antidepressants that exhibit rapid onset of action with greater efficacy and fewer side effects.
650
0
$a
Melatonin.
$3
649179
650
0
$a
Melatonin
$x
Therapeutic use.
$3
678745
650
0
$a
Antidepressants.
$3
252255
650
0
$a
Medicine.
$3
193819
650
0
$a
Internal medicine.
$3
306407
650
0
$a
Neurology.
$3
211583
650
0
$a
Psychopharmacology.
$3
252258
650
1 4
$a
Medicine & Public Health.
$3
273799
650
2 4
$a
Internal Medicine.
$3
273839
700
1
$a
Lopez-Munoz, Francisco.
$3
763254
710
2
$a
SpringerLink (Online service)
$3
273601
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-81-322-2803-5
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000134440
電子館藏
1圖書
電子書
EB RM297.M44 M517 2016
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-81-322-2803-5
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入